Guardant Health Inc- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于 Guardant Health Inc 公司

Guardant Health, Inc. 是一家精准肿瘤学公司，致力于守护健康并让每个人有更多时间远离癌症。该公司通过先进的血液和组织测试、真实世界数据和人工智能 (AI) 分析，提供有关疾病驱动因素的关键见解。Guardant 测试有助于改善所有护理阶段的结果，包括筛查以尽早发现癌症、监测早期癌症的复发以及帮助医生为晚期癌症患者选择最佳治疗方法。对于晚期癌症患者，该公司开发了 Guardant360 实验室开发测试 (LDT) 和 Guardant360 CDx，这是一种全面的液体活检测试，可为实体肿瘤提供肿瘤突变分析，并可用作非小细胞肺癌 (NSCLC) 和乳腺癌的伴随诊断。该公司还提供其他测试，包括 Guardant360 TissueNext 组织测试、Guardant Reveal 血液测试、Guardant360 Response 血液测试等。

Guardant Health Inc简介



公司代码GH

公司名称Guardant Health Inc

上市日期Oct 04, 2018

CEODr. Amirali Talasaz, Ph.D.

员工数量1999

证券类型Ordinary Share

年结日Oct 04

公司地址3100 Hanover Street

城市PALO ALTO

上市交易所NASDAQ Global Select Consolidated

国家United States of America

邮编94304

电话18556988887

网址https://guardanthealth.com/

公司代码GH

上市日期Oct 04, 2018

CEODr. Amirali Talasaz, Ph.D.

Guardant Health Inc公司高管



名称

名称/职务

职务

持股

持股变动

Dr. Amirali Talasaz, Ph.D.

Co-Chief Executive Officer, Director

2.52M

+0.47%

Dr. Helmy A. Eltoukhy, Ph.D.

Chairperson of the Board, Co-Chief Executive Officer

2.47M

+0.48%

Dr. Darya Chudova

Chief Technology Officer

88.53K

+9.85%

Mr. John Gomes Saia

Chief Legal Officer, Corporate Secretary

52.17K

+14.83%

Mr. Craig Eagle, M.D.

Chief Medical Officer

44.32K

+18.23%

Ms. Vijaya V. Gadde

Independent Director

24.31K

+37.83%

Mr. Kumud Kalia

Chief Information Officer

21.68K

+31.56%

Ms. Myrtle Stephens Potter

Independent Director

18.28K

+0.23%

Ms. Meghan V. Joyce

Independent Director

11.18K

-0.89%

Mr. Musa Tariq

Independent Director

7.59K

+1.78%

名称

名称/职务

职务

持股

持股变动

Dr. Amirali Talasaz, Ph.D.

Co-Chief Executive Officer, Director

2.52M

+0.47%

Dr. Helmy A. Eltoukhy, Ph.D.

Chairperson of the Board, Co-Chief Executive Officer

2.47M

+0.48%

Dr. Darya Chudova

Chief Technology Officer

88.53K

+9.85%

Mr. John Gomes Saia

Chief Legal Officer, Corporate Secretary

52.17K

+14.83%

Mr. Craig Eagle, M.D.

Chief Medical Officer

44.32K

+18.23%

Ms. Vijaya V. Gadde

Independent Director

24.31K

+37.83%

收入明细

单位: USD更新时间: 7 小时前

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

业务USD

名称

营收

占比

Oncology

158.69M

68.37%

Biopharma and data

56.02M

24.14%

Screening

14.81M

6.38%

Licensing and other

2.57M

1.11%

地区USD

名称

营收

占比

United States

216.68M

93.36%

International

15.40M

6.64%

业务

地区

业务USD

名称

营收

占比

Oncology

158.69M

68.37%

Biopharma and data

56.02M

24.14%

Screening

14.81M

6.38%

Licensing and other

2.57M

1.11%

股东统计

更新时间: 9月28日周日

持股股东

股东类型

持股股东

占比

The Vanguard Group, Inc.

9.74%

BlackRock Institutional Trust Company, N.A.

6.73%

Capital International Investors

3.99%

Baillie Gifford & Co.

3.86%

Deep Track Capital LP

3.41%

其他

72.28%

持股股东

占比

The Vanguard Group, Inc.

9.74%

BlackRock Institutional Trust Company, N.A.

6.73%

Capital International Investors

3.99%

Baillie Gifford & Co.

3.86%

Deep Track Capital LP

3.41%

其他

72.28%

股东类型

持股股东

占比

Investment Advisor

45.84%

Investment Advisor/Hedge Fund

27.21%

Hedge Fund

19.41%

Individual Investor

4.36%

Bank and Trust

2.25%

Sovereign Wealth Fund

1.83%

Research Firm

1.74%

Pension Fund

1.17%

Family Office

0.03%

机构持股



更新时间: 10月1日周三

报告期

机构数

持股数

持股占比

持股变动

2025Q3

750

124.14M

99.55%

-16.44M

2025Q2

759

134.16M

107.59%

-14.14M

2025Q1

783

130.34M

105.23%

-16.59M

2024Q4

746

130.16M

105.47%

-20.09M

2024Q3

780

137.29M

111.53%

-9.70M

2024Q2

801

127.50M

103.74%

-18.45M

2024Q1

826

124.00M

101.88%

-12.71M

2023Q4

856

120.18M

99.30%

-14.26M

2023Q3

867

117.78M

100.31%

-19.15M

2023Q2

890

119.83M

102.55%

+840.96K

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

The Vanguard Group, Inc.

12.14M

9.74%

+89.50K

+0.74%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

8.39M

6.73%

-215.41K

-2.50%

Jun 30, 2025

Capital International Investors

4.98M

3.99%

-171.27K

-3.33%

Jun 30, 2025

Baillie Gifford & Co.

4.81M

3.86%

-251.22K

-4.96%

Jun 30, 2025

Deep Track Capital LP

4.25M

3.41%

-1.19M

-21.93%

Jun 30, 2025

Two Sigma Investments, LP

4.24M

3.4%

+42.75K

+1.02%

Jun 30, 2025

Eventide Asset Management, LLC

3.46M

2.77%

-107.78K

-3.02%

Jun 30, 2025

Invesco Advisers, Inc.

3.40M

2.73%

+789.69K

+30.20%

Jun 30, 2025

Cadian Capital Management LP

3.18M

2.55%

-1.42M

-30.81%

Jun 30, 2025

Citadel Advisors LLC

2.94M

2.36%

-658.36K

-18.30%

Jun 30, 2025

持股ETF



更新时间: 17 小时前

机构名称

占比

Global X Genomics & Biotechnology ETF

5.38%

ARK Genomic Revolution ETF

5.3%

Franklin Genomic Advancements ETF

5.28%

First Trust Nasdaq Lux Digi Health Solutions ETF

3.58%

Invesco Dorsey Wright Healthcare Momentum ETF

3.15%

SPDR S&P Health Care Services ETF

2.68%

Alger Mid Cap 40 ETF

2.55%

ROBO Global Healthcare Technology & Innovation ETF

2.47%

iShares Health Innovation Active ETF

1.92%

iShares U.S. Healthcare Providers ETF

1.37%

Global X Genomics & Biotechnology ETF

占比5.38%

ARK Genomic Revolution ETF

占比5.3%

Franklin Genomic Advancements ETF

占比5.28%

First Trust Nasdaq Lux Digi Health Solutions ETF

占比3.58%

Invesco Dorsey Wright Healthcare Momentum ETF

占比3.15%

SPDR S&P Health Care Services ETF

占比2.68%

Alger Mid Cap 40 ETF

占比2.55%

ROBO Global Healthcare Technology & Innovation ETF

占比2.47%

iShares Health Innovation Active ETF

占比1.92%

iShares U.S. Healthcare Providers ETF

占比1.37%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据